Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Windward Bio closed its IPO of 11,838,234 common shares at $17.00 per share, including full exercise of the underwriters' option, with combined gross proceeds of approximately $251.2 million alongside a concurrent private placement. Sanofi Foreign Participations B.V. purchased 1,532,691 shares plus pre-funded warrants for 1,408,485 shares for $50.0 million in an unregistered private placement at the IPO price.
Key figures
- Deal Value Usd
- 251200000
- Offering Price
- 17
- Shares Offered
- 11838234
- Prefunded warrant shares
- 1408485
- Private placement shares
- 1532691
- Private placement proceeds
- 50000000
- Underwriters option shares
- 1544117
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.